Citigroup Inc. Reduces Stake in Zimmer Biomet Holdings

Medical device company Zimmer Biomet sees institutional investor exit position

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Citigroup Inc. has reduced its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a major medical equipment provider, by 14.8% in the third quarter. The institutional investor now owns 145,608 shares of the company's stock, down from 170,942 shares previously.

Why it matters

Zimmer Biomet is a leading manufacturer of orthopedic implants and other medical devices. Changes in institutional ownership can signal shifts in investor sentiment and market dynamics around the company's performance and future prospects.

The details

According to a regulatory filing, Citigroup sold 25,334 shares of Zimmer Biomet in the third quarter, reducing its total position to 145,608 shares. Citigroup previously owned 0.07% of Zimmer Biomet's outstanding shares, which are now valued at $14.3 million.

  • Citigroup reduced its Zimmer Biomet stake in the 3rd quarter of 2026.

The players

Citigroup Inc.

A multinational investment bank and financial services corporation.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Citigroup's Zimmer Biomet holdings may indicate a shift in investor sentiment around the medical device company's performance and future outlook, though further analysis would be needed to determine the broader implications.